{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:08:57Z","timestamp":1790845737928,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,11,12]],"date-time":"2014-11-12T00:00:00Z","timestamp":1415750400000},"content-version":"vor","delay-in-days":346,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Conselho Nacional de Desenvolvimento Cient\u00edfico,CNPq, Brazil"},{"name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior, Capes \u2014 Toxinologia\/Capes"},{"name":"Instituto Nacional de Ci\u00eancia e Tecnologia (INCT) em Medicina Molecular (MCT\/CNPq)"},{"DOI":"10.13039\/501100004901","name":"FAPEMIG","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.pbb.2013.10.014","type":"journal-article","created":{"date-parts":[[2013,10,19]],"date-time":"2013-10-19T10:46:17Z","timestamp":1382179577000},"page":"16-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"special_numbering":"C","title":["Effect of \u03c9-conotoxin MVIIA and Ph\u03b11\u03b2 on paclitaxel-induced acute and chronic pain"],"prefix":"10.1016","volume":"114-115","author":[{"given":"Fl\u00e1via K.","family":"Rigo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerusa D.","family":"Dalmolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Trevisan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Tonello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariane A.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateus F.","family":"Rossato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonatas Z.","family":"Klafke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta do N.","family":"Cordeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9lio J.","family":"Castro Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danuza","family":"Montijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus V.","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliano","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2013.10.014_bb0005","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(10)60354-6","article-title":"Ziconotide for treatment of severe chronic pain","volume":"375","author":"Achim","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.pbb.2013.10.014_bb0010","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/08941939.2012.713444","article-title":"Antioxidants and gabapentin prevent heat hypersensitivity in a neuropathic pain model","volume":"26","author":"Arcos","year":"2013","journal-title":"J Invest Surg"},{"key":"10.1016\/j.pbb.2013.10.014_bb0015","doi-asserted-by":"crossref","first-page":"61","DOI":"10.33588\/rn.5201.2010475","article-title":"Neuropsychiatric side effects of intrathecal ziconotide","volume":"52","author":"Ayuga-Loro","year":"2011","journal-title":"Rev Neurol"},{"key":"10.1016\/j.pbb.2013.10.014_bb0020","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuropharm.2013.04.001","article-title":"Ph\u03b11\u03b2 toxin prevents capsaicin-induced nociceptive behavior and mechanical hypersensitivity without acting on TRPV1 channels","volume":"71","author":"Castro-Junior","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2013.10.014_bb0025","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.pbb.2013.10.014_bb0030","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0041-0101(93)90354-L","article-title":"Purification and amino acid sequences of six Tx3 type neurotoxins from the venom of the Brazilian \u2018armed\u2019 spider Phoneutria nigriventer (Keys)","volume":"31","author":"Cordeiro","year":"1993","journal-title":"Toxicon"},{"key":"10.1016\/j.pbb.2013.10.014_bb0035","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/j.pain.2011.04.015","article-title":"Antinociceptive effect of Brazilian armed spider venom toxin Tx3-3 in animal models of neuropathic pain","volume":"152","author":"Dalmolin","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.pbb.2013.10.014_bb0045","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.toxicon.2011.09.008","article-title":"Antiallodynic effect and side effects of Ph\u03b11\u03b2, a neurotoxin from the spider Phoneutria nigriventer: Comparison with \u03c9-conotoxin MVIIA and morphine","volume":"58","author":"de Souza","year":"2011","journal-title":"Toxicon"},{"key":"10.1016\/j.pbb.2013.10.014_bb0040","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10571-012-9871-x","article-title":"An evaluation of the antinociceptive effects of Ph\u03b11\u03b2, a neurotoxin from the spider Phoneutria nigriventer, and \u03c9-conotoxin MVIIA, a cone snail Conus magus toxin, in rat model of inflammatory and neuropathic pain","volume":"33","author":"de Souza","year":"2013","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.pbb.2013.10.014_bb0055","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.pain.2004.01.021","article-title":"Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients","volume":"109","author":"Dougherty","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.pbb.2013.10.014_bb0060","doi-asserted-by":"crossref","first-page":"20171","DOI":"10.1074\/jbc.M300581200","article-title":"Determinants of inhibition of transiently expressed voltage-gated calcium channels by omega-conotoxins GVIA and MVIIA","volume":"278","author":"Feng","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pbb.2013.10.014_bb0065","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.pain.2004.01.029","article-title":"Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy","volume":"109","author":"Flatters","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.pbb.2013.10.014_bb0070","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1023\/A:1005805907311","article-title":"Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing","volume":"35","author":"Forsyth","year":"1997","journal-title":"J Neurooncol"},{"key":"10.1016\/j.pbb.2013.10.014_bb0075","first-page":"271","article-title":"Myalgias and arthralgias associated with paclitaxel","volume":"17","author":"Garrison","year":"2003","journal-title":"Oncology"},{"key":"10.1016\/j.pbb.2013.10.014_bb0080","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1200\/JCO.1997.15.5.1965","article-title":"Phase I dose escalation of paclitaxel in patients with advanced ovarian cancer receiving cisplatin: rapid development of neurotoxicity is dose-limiting","volume":"15","author":"Gordon","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.pbb.2013.10.014_bb0085","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1093\/jnci\/83.24.1797-a","article-title":"Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer","volume":"83","author":"Holmes","year":"1991","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.pbb.2013.10.014_bb0090","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1254\/jphs.12123FP","article-title":"Paclitaxel increases high voltage-dependent calcium channel current in dorsal root ganglion neurons of the rat","volume":"120","author":"Kawakami","year":"2012","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.pbb.2013.10.014_bb0100","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1006\/mcne.1994.1026","article-title":"Characterization of the binding of omega-conopeptides to different classes of non-L-type neuronal calcium channels","volume":"5","author":"Kristipati","year":"1994","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.pbb.2013.10.014_bb0095","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s12272-013-0057-y","article-title":"Implications and mechanism of action of gabapentin in neuropathic pain","volume":"36","author":"Kukkar","year":"2013","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.pbb.2013.10.014_bb0105","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/PPO.0b013e31815a999b","article-title":"The Paclitaxel acute pain syndrome: sensitization of nociceptors as the putative mechanism","volume":"13","author":"Loprinzi","year":"2007","journal-title":"Cancer J"},{"key":"10.1016\/j.pbb.2013.10.014_bb0110","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1200\/JCO.2010.33.0308","article-title":"Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1","volume":"29","author":"Loprinzi","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.pbb.2013.10.014_bb0115","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.pain.2010.10.007","article-title":"Increased risk of suicide under intrathecal ziconotide treatment? \u2014 A warning","volume":"152","author":"Maier","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.pbb.2013.10.014_bb0120","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1523\/JNEUROSCI.14-08-04882.1994","article-title":"Voltage-sensitive calcium channels in spinal nociceptive processing: blockade of N- and P-type channels inhibits formalin-induced nociception","volume":"14","author":"Malmberg","year":"1994","journal-title":"J Neurosci"},{"key":"10.1016\/j.pbb.2013.10.014_bb0125","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1213\/ANE.0b013e31824b0191","article-title":"Prevention of paclitaxel-induced neuropathy through activation of the central cannabinoid type 2 receptor system","volume":"114","author":"Naguib","year":"2012","journal-title":"Anesth Analg"},{"key":"10.1016\/j.pbb.2013.10.014_bb0130","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0304-3959(99)00254-7","article-title":"Adverse effects associated with the intrathecal administration of ziconotide","volume":"85","author":"Penn","year":"2000","journal-title":"Pain"},{"key":"10.1016\/j.pbb.2013.10.014_bb0135","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.nurt.2009.07.006","article-title":"Targeting voltage-gated calcium channels for neuropathic pain management","volume":"6","author":"Perret","year":"2009","journal-title":"Neurotherapeutics"},{"issue":"8","key":"10.1016\/j.pbb.2013.10.014_bb0140","first-page":"54","article-title":"CRMP-2 peptide mediated decrease of high and low voltage-activated calcium channels, attenuation of nociceptor excitability, and anti-nociception in a model of AIDS therapy-induced painful peripheral neuropathy","volume":"24","author":"Piekarz","year":"2012","journal-title":"Mol Pain"},{"key":"10.1016\/j.pbb.2013.10.014_bb0145","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1046\/j.1526-4637.2001.002001008.x","article-title":"Chemotherapy-evoked painful peripheral neuropathy","volume":"2","author":"Polomano","year":"2001","journal-title":"Pain Med"},{"key":"10.1016\/j.pbb.2013.10.014_bb0150","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0304-3959(01)00363-3","article-title":"A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel","volume":"94","author":"Polomano","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.pbb.2013.10.014_bb0155","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1358\/dot.2006.42.6.973534","article-title":"Ziconotide: a new option for refractory pain","volume":"42","author":"Prommer","year":"2006","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.pbb.2013.10.014_bb0160","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1533-2500.2009.00303.x","article-title":"Intrathecal ziconotide for neuropathic pain: a review","volume":"9","author":"Rauck","year":"2009","journal-title":"Pain Pract"},{"key":"10.1016\/j.pbb.2013.10.014_bb0165","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1002\/cncr.27489","article-title":"Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy: North Central Cancer Treatment Group trial N08C1","volume":"118","author":"Reeves","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.pbb.2013.10.014_bb0170","first-page":"1","article-title":"Spider peptide Ph\u03b11\u03b2 induces analgesic effect in a model of cancer pain","volume":"29","author":"Rigo","year":"2013","journal-title":"Cancer Sci"},{"key":"10.1016\/j.pbb.2013.10.014_bb0175","first-page":"1","article-title":"Clinical toxicities encountered by paclitaxel (Taxol)","volume":"20","author":"Rowinsky","year":"1993","journal-title":"Semin Oncol"},{"key":"10.1016\/j.pbb.2013.10.014_bb0180","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00280-007-0584-7","article-title":"Successful amelioration of oxaliplatin-induced hyperexcitability syndrome with the antiepileptic pregabalin in a patient with pancreatic cancer","volume":"61","author":"Saif","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.pbb.2013.10.014_bb0185","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.expneurol.2006.05.007","article-title":"Paclitaxel- and vincristine-evoked painful peripheral neuropathies: loss of epidermal innervation and activation of Langerhans cells","volume":"201","author":"Siau","year":"2006","journal-title":"Exp Neurol"},{"key":"10.1016\/j.pbb.2013.10.014_bb0190","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0304-3959(01)00436-5","article-title":"The novel N-type calcium channel blocker, AM336, produces potent dose-dependent antinociception after intrathecal dosing in rats and inhibits substance P release in rat spinal cord slices","volume":"96","author":"Smith","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.pbb.2013.10.014_bb0195","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1602\/neurorx.2.4.662","article-title":"Targeting chronic and neuropathic pain: the N-type calcium channel comes of age","volume":"2","author":"Snutch","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.pbb.2013.10.014_bb0200","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.pain.2008.07.014","article-title":"Analgesic effect in rodents of native and recombinant Ph alpha 1beta toxin, a high-voltage-activated calcium channel blocker isolated from armed spider venom","volume":"140","author":"Souza","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.pbb.2013.10.014_bb0205","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/jama.291.1.63","article-title":"Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial","volume":"291","author":"Staats","year":"2004","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.pbb.2013.10.014_bb0210","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1523\/JNEUROSCI.17-09-03002.1997","article-title":"Preferential interaction of omega-conotoxins with inactivated N-type Ca2+ channels","volume":"17","author":"Stocker","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.pbb.2013.10.014_bb0215","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1124\/jpet.105.087023","article-title":"Inhibition of high voltage-activated calcium channels by spider toxin p nTx3\u20136","volume":"314","author":"Vieira","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2013.10.014_bb0220","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/PL00005150","article-title":"Peripheral versus central potencies of N-type voltage-sensitive calcium channel blockers","volume":"357","author":"Wang","year":"1998","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.pbb.2013.10.014_bb0225","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1200\/JCO.1996.14.7.1993","article-title":"Phase II trial of paclitaxel and cisplatin in women with advanced breast cancer: an active regimen with limiting neurotoxicity","volume":"14","author":"Wasserheit","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.pbb.2013.10.014_bb0230","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.bcp.2005.04.035","article-title":"Use-dependent blockade of Cav2.2 voltage-gated calcium channels for neuropathic pain","volume":"70","author":"Winquist","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pbb.2013.10.014_bb0235","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.ejca.2008.04.018","article-title":"Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies","volume":"44","author":"Woolf","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.pbb.2013.10.014_bb0240","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.neuroscience.2006.09.044","article-title":"Chemotherapy-evoked painful peripheral neuropathy: analgesic effects of gabapentin and effects on expression of the alpha-2-delta type-1 calcium channel subunit","volume":"144","author":"Xiao","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2013.10.014_bb0245","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.brainresrev.2008.12.021","article-title":"Role of voltage-gated calcium channels in ascending pain pathways","volume":"60","author":"Zamponi","year":"2009","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.pbb.2013.10.014_bb0250","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigations of experimental pain in conscious animals","volume":"16","author":"Zimmermann","year":"1983","journal-title":"Pain"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305713002608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305713002608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:32:37Z","timestamp":1758774757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305713002608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":49,"alternative-id":["S0091305713002608"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2013.10.014","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of \u03c9-conotoxin MVIIA and Ph\u03b11\u03b2 on paclitaxel-induced acute and chronic pain","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2013.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}